Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease
Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease
Not yet recruiting · NCT07671222 · Registry updated 2026-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease | Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorder | Not yet recruiting | Phase 2 | 2026-06-26 | NCT07671222 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Instituto de Oftalmología Fundación Conde de Valenciana | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Instituto de Oftalmología Conde de Valenciana | Mexico City | Mexico | 2 |